Evidence for supplementation with cholecalciferol or ergocalciferol in late-stage CKD is based on very limited clinical studies, both in quality and in statistical power, and have not shown consistent results with regard to parathyroid hormone suppression [30, 31]. Here, PTH is linked to chronic kidney disease.